Terns Pharmaceuticals Inc (TERN)
6.15
-0.40
(-6.11%)
USD |
NASDAQ |
Nov 15, 11:47
Terns Pharmaceuticals Cash and Short Term Investments (Quarterly): 225.30M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 225.30M |
| March 31, 2024 | 240.65M |
| December 31, 2023 | 263.44M |
| September 30, 2023 | 266.60M |
| June 30, 2023 | 285.60M |
| March 31, 2023 | 297.53M |
| December 31, 2022 | 283.11M |
| September 30, 2022 | 187.29M |
| June 30, 2022 | 139.81M |
| Date | Value |
|---|---|
| March 31, 2022 | 151.27M |
| December 31, 2021 | 165.98M |
| September 30, 2021 | 177.20M |
| June 30, 2021 | 185.08M |
| March 31, 2021 | 195.58M |
| December 31, 2020 | 74.85M |
| September 30, 2020 | 13.76M |
| December 31, 2019 | 19.65M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
13.76M
Minimum
Sep 2020
297.53M
Maximum
Mar 2023
186.63M
Average
187.29M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 3.518B |
| Viking Therapeutics Inc | 930.44M |
| Biomarin Pharmaceutical Inc | 930.44M |
| Elite Pharmaceuticals Inc | 8.407M |
| Verrica Pharmaceuticals Inc | 22.96M |